Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) - free report >>
Image: Bigstock
Long-Short ETF (BTAL) Hits New 52-Week High
For investors seeking momentum, AGF U.S. Market Neutral Anti-Beta Fund (BTAL - Free Report) is probably on the radar. The fund just hit a 52-week high of $22.10 from its 52-week low price of $17.59/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea of where it might be headed:
BTAL in Focus
The AGF U.S. Market Neutral Anti-Beta Fund seeks to provide a consistent negative beta exposure to the U.S. equity market. The expense ratio of the fund is 1.58%. The dividend yield of the fund is 3.02% annually.
Why the Move?
The long-short corner of the broad ETF world has been an area to watch lately, given the heightened volatility and uncertainty. Amid concerns over trade tensions and potential recession risks, stocks have faced challenges recently. In such a scenario, investing in long-short ETFs seems prudent, as they offer a defensive stance to one’s portfolio.
More Gains Ahead?
The fund has a positive weighted alpha of 18.15. So, there is a great outlook ahead for those who want to ride this surging ETF.